Skip to main content
PW Medtech Group Limited logo

PW Medtech Group Limited — Investor Relations & Filings

Ticker · 1358 ISIN · KYG7306W1087 LEI · 894500L18EYHNJR6VJ41 HKEX Manufacturing
Open in API
Filings indexed 765 across all filing types
Latest filing 2025-07-04 Transaction in Own Shar…
Country KY Cayman Islands
Listing HKEX 1358

About PW Medtech Group Limited

http://www.pwmedtech.com

PW Medtech Group Limited is a medical device company engaged in the research, development, production, and sale of advanced infusion therapy products. The company's core portfolio includes specialized infusion sets and related accessories, such as non-PVC and DEHP-free infusion systems, precision filter infusion sets, light-resistant infusion sets, and safety IV catheters. Operating primarily in China, India, the Americas, and Africa, the Group emphasizes patient and clinician safety. Key innovations include positive pressure needleless connectors designed to prevent blood backflow and contamination, and safety-engineered devices utilizing double-layer tubing (TPU/PVC) and high-precision filtration to mitigate needlestick injuries and adverse infusion reactions.

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE UNDER THE REPURCHASE MANDATE
Transaction in Own Shares Classification · 1% confidence The document is a voluntary announcement by PW Medtech Group Limited regarding the implementation of a share repurchase plan under an existing repurchase mandate. It details the buyback mechanism, timing, pricing limits, and compliance with listing rules. This matches the definition of "Transaction in Own Shares" (share repurchase/issuance), fitting code POS.
2025-07-04 English
EARLY REPAYMENT OF LOAN
Capital/Financing Update Classification · 1% confidence The document is an announcement filed by PW Medtech Group Limited on HKEX regarding an early repayment of part of a loan under an existing Loan Agreement and Supplemental Loan Agreement. It describes the financing arrangement, principal amount repaid, outstanding principal terms unchanged, and security provisions. This constitutes an update on the company’s financing activities rather than an earnings report, management presentation, or regulatory form. Therefore, it best fits the Capital/Financing Update category (CAP).
2025-07-04 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2025
Regulatory Filings Classification · 1% confidence The document is a standardized monthly return (Form FF301) submitted to the Hong Kong Exchange under Listing Rule Chapter 19B, detailing movements in authorised, issued, and treasury share capital. It is not a financial report (annual, interim, earnings) nor a one-off share issuance notice or buyback announcement, but a periodic regulatory submission. It therefore falls into the general regulatory announcements/fallback category.
2025-07-04 English
VOLUNTARY ANNOUNCEMENT - PROGRESS ON THE SUBSEQUENT LISTING OF SICHUAN RUIJIAN MEDICAL ON BEIJING STOCK EXCHANGE
Capital/Financing Update Classification · 1% confidence The document is a voluntary corporate announcement on HKEX by PW Medtech Group updating shareholders about the progress on a major transaction—a subsequent listing of its subsidiary (Sichuan Ruijian Medical) on the Beijing Stock Exchange. It details the review status, suspension of the listing process, and references earlier transaction announcements. This is not an earnings release, call transcript, AGM material, or annual/interim report, but rather an update on a capital transaction and listing process. Therefore it best fits the "Capital/Financing Update" category (CAP).
2025-06-20 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 10, 2025
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official announcement of the poll voting results at the company’s Annual General Meeting (AGM) held on June 10, 2025. It lists each resolution, vote counts for and against, and confirms all resolutions were passed. This clearly matches the definition of “Declaration of Voting Results & Voting Rights Announcements” (Code: DVA).
2025-06-10 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2025
Regulatory Filings Classification · 1% confidence The document is a standard Hong Kong Exchange Listing Rules form FF301: Monthly Return for Equity Issuers and Hong Kong Depositary Receipts, reporting movement in share capital, issued shares, and treasury shares. It does not present financial results (Earnings Release), full periodic report (Annual or Interim Report), nor is it an investor presentation, call transcript, or M&A announcement. It is a routine regulatory submission under the listing rules, which does not fit any more specific category. This matches the fallback “Regulatory Filings” category (Code: RNS).
2025-06-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.